Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.
Last action: 2026-03-12 — By resolution, returned to Senate Rules Committee for third reading.
Take Action
Official Description
Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.
Bill Details
- Bill Number
- SB 5594
- Current Status
- Engrossed
- Sponsors
- Paul Harris, Annette Cleveland, Robert Hasegawa, Sharon Shewmake
- Introduced
- 2025-01-30
- Chamber
- Senate
- Current Committee
- Rules
Floor Votes
| Date | Chamber | Motion | Result | Democrats | Republicans |
|---|---|---|---|---|---|
| 2025-03-11 | Senate | 3rd Reading & Final Passage2ESSB 5594 | Passed 49-0 | 27 yes / 0 no | 19 yes / 0 no |
| 2026-01-21 | Senate | 3rd Reading & Final Passage2ESSB 5594 | Passed 49-0 | 28 yes / 0 no | 19 yes / 0 no |
Official roll calls from the Washington State Legislature. See each legislator's page for how they voted.
Bill History
- 2026-01-21 Returned to second reading for amendment.
- 2026-01-21 Floor amendment
- 2026-01-21 Rules suspended. Placed on Third Reading.
- 2026-01-21 Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
- 2026-01-26 First reading, referred to Health Care & Wellness.
- 2026-02-10 Public hearing in the House Committee on Health Care & Wellness at 8:30 AM.
- 2026-02-25 Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
- 2026-02-25 HCW - Majority; do pass.
- 2026-02-25 Referred to Rules 2 Review.
- 2026-03-12 By resolution, returned to Senate Rules Committee for third reading.
How to Make Your Voice Heard
1. Submit Written Comment
Click "Comment on This Bill" above. You have up to 5,000 characters. Comments are typically open for 24 hours before hearings.
2. Testify at Hearing
Sign up to testify remotely via TVW. Check the legislative calendar for hearing times.
3. Contact Your Legislator
Use the district finder to find your representatives and reach out directly.